A composite urine biomarker reflects interstitial inflammation in lupus nephritis kidney biopsies.


The initial treatment of lupus nephritis is usually based on a renal biopsy. Subsequent disease flares, however, are often treated without the benefit of kidney pathology because repeat biopsies are infrequent. A noninvasive, real-time method to assess renal pathology would be useful to adjust treatment and improve outcome. To develop such a method we… (More)
DOI: 10.1038/ki.2011.354


  • Presentations referencing similar topics